Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding
- PMID: 2543930
- DOI: 10.1038/339548a0
Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding
Abstract
Interactions of CD4 with the class II major histocompatibility complex (MHC) are crucial during thymic ontogeny and subsequently for helper and cytotoxic functions of CD4+CD8- T lymphocytes. CD4 is the receptor for the T-lymphotropic human immunodeficiency virus and binds its envelope glycoprotein, gp120. The residues involved in gp120 binding have been localized to a region within the immunoglobulin-like domain I of CD4, which corresponds to CDR2 of an immunoglobulin variable region, but the CD4 residues important in MHC class II interaction have not been characterized. Here, using a cell-binding assay dependent specifically on the CD4-MHC class II association, we analyse the effects of mutations in CD4 on class II versus gp120 binding. Mutations in CDR2 that destroy gp120 binding affect CD4-MHC class II binding similarly. In addition, binding of soluble gp120 to CD4-transfected cells abrogates their ability to interact with class II-bearing B lymphocytes. In contrast, other mutations within domains I or II that have no effect on gp120 binding eliminate or substantially decrease class II interaction. Thus, the CD4 binding site for class II MHC is more complex than the gp120 binding site, possibly reflecting a broader area of contact with the former ligand and a requirement for appropriate juxtaposition of the two N-terminal domains. The ability of gp120 to inhibit the binding of class II MHC to CD4 could be important in disrupting normal T-cell physiology, acting both to inhibit immune responses and to prevent differentiation of CD4+CD8+ thymocytes into CD4+CD8- T lymphocytes.
Similar articles
-
Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.Cell Immunol. 1994 Apr 15;155(1):169-82. doi: 10.1006/cimm.1994.1110. Cell Immunol. 1994. PMID: 8168144
-
The MHC-binding and gp120-binding functions of CD4 are separable.Science. 1989 Aug 18;245(4919):743-6. doi: 10.1126/science.2549633. Science. 1989. PMID: 2549633
-
A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.Nature. 1988 Jan 7;331(6151):78-81. doi: 10.1038/331078a0. Nature. 1988. PMID: 2829023
-
The interaction of CD4 with HIV-1 gp120.Semin Immunol. 1991 May;3(3):187-92. Semin Immunol. 1991. PMID: 1888898 Review.
-
Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.Crit Rev Immunol. 1988;8(4):315-39. Crit Rev Immunol. 1988. PMID: 2850890 Review.
Cited by
-
HLA-transgenic mouse models to study autoimmune central nervous system diseases.Autoimmunity. 2024 Dec;57(1):2387414. doi: 10.1080/08916934.2024.2387414. Epub 2024 Aug 21. Autoimmunity. 2024. PMID: 39167553 Review.
-
Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse.J Exp Med. 1990 Aug 1;172(2):567-75. doi: 10.1084/jem.172.2.567. J Exp Med. 1990. PMID: 2142721 Free PMC article.
-
Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding.Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8259-63. doi: 10.1073/pnas.90.17.8259. Proc Natl Acad Sci U S A. 1993. PMID: 8367491 Free PMC article.
-
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.Microbiol Rev. 1996 Jun;60(2):386-406. doi: 10.1128/mr.60.2.386-406.1996. Microbiol Rev. 1996. PMID: 8801439 Free PMC article. Review.
-
Divergent evolution may link human immunodeficiency virus GP41 to human CD4.J Mol Evol. 1993 May;36(5):448-57. doi: 10.1007/BF02406721. J Mol Evol. 1993. PMID: 8510178
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials